Disease Name filter_list |
Disease Category filter_list |
DSI* filter_list |
DPI** filter_list |
Alcoholic Intoxication |
Chemically-Induced Disorders ; Mental Disorders ; |
0.503 |
0.793 |
Alzheimer's Disease |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Apnea |
Respiratory Tract Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Bipolar Disorder |
Mental Disorders ; |
0.503 |
0.793 |
Malignant neoplasm of breast |
Neoplasms ; Skin and Connective Tissue Diseases ; |
0.503 |
0.793 |
Renal Cell Carcinoma |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Cocaine Abuse |
Chemically-Induced Disorders ; Mental Disorders ; |
0.503 |
0.793 |
Cognition Disorders |
Mental Disorders ; |
0.503 |
0.793 |
Presenile dementia |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Drug toxicity |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Tonic-Clonic Epilepsy |
Nervous System Diseases ; |
0.503 |
0.793 |
Muscular fasciculation |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Glioblastoma |
Neoplasms ; |
0.503 |
0.793 |
Hemiparesis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Hypersomnia with Periodic Respiration |
Respiratory Tract Diseases ; Nervous System Diseases ; |
0.503 |
0.793 |
Hypertriglyceridemia |
Nutritional and Metabolic Diseases ; |
0.503 |
0.793 |
Jacksonian Seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Multiple Sclerosis |
Nervous System Diseases ; Immune System Diseases ; |
0.503 |
0.793 |
Muscular Dystrophy |
Musculoskeletal Diseases ; Nervous System Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; |
0.503 |
0.793 |
Neuroblastoma |
Neoplasms ; |
0.503 |
0.793 |
Obesity |
Nutritional and Metabolic Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Paresis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Poisoning |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Postoperative Complications |
Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Sleep Apnea Syndromes |
Respiratory Tract Diseases ; Nervous System Diseases ; |
0.503 |
0.793 |
Tachycardia |
Cardiovascular Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Trismus |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Adverse reaction to drug |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Tachyarrhythmia |
Cardiovascular Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Encephalopathy, Toxic |
Nervous System Diseases ; Chemically-Induced Disorders ; |
0.503 |
0.793 |
Complex partial seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Toxic Encephalitis |
Nervous System Diseases ; Chemically-Induced Disorders ; |
0.503 |
0.793 |
Generalized seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures, Clonic |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Todd Paralysis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Neurotoxicity Syndromes |
Nervous System Diseases ; Chemically-Induced Disorders ; |
0.503 |
0.793 |
Cocaine-Related Disorders |
Chemically-Induced Disorders ; Mental Disorders ; |
0.503 |
0.793 |
Fasciculation, Tongue |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Masseter Muscle Spasm |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Pseudocholinesterase deficiency |
Respiratory Tract Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Monoparesis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Visual seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Tonic Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Epileptic drop attack |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Familial Alzheimer Disease (FAD) |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Conventional (Clear Cell) Renal Cell Carcinoma |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Giant Cell Glioblastoma |
Neoplasms ; |
0.503 |
0.793 |
Sleep Apnea, Mixed Central and Obstructive |
Respiratory Tract Diseases ; Nervous System Diseases ; |
0.503 |
0.793 |
Lockjaw |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Organophosphorus Poisoning |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Cardiac Death |
Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures, Somatosensory |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures, Auditory |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Olfactory seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Gustatory seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Vertiginous seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Hyperactive behavior |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Alzheimer Disease, Late Onset |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Tonic - clonic seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Paralysed |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Fasciculation, Skeletal Muscle |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Acute Confusional Senile Dementia |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Cocaine Dependence |
Chemically-Induced Disorders ; Mental Disorders ; |
0.503 |
0.793 |
Breast Carcinoma |
Neoplasms ; Skin and Connective Tissue Diseases ; |
0.503 |
0.793 |
Organophosphate poisoning |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Alzheimer's Disease, Focal Onset |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Alzheimer Disease, Early Onset |
Nervous System Diseases ; Mental Disorders ; |
0.503 |
0.793 |
Non-epileptic convulsion |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Single Seizure |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Cryptogenic Tonic-Clonic Epilepsy |
Nervous System Diseases ; |
0.503 |
0.793 |
Epilepsy, Tonic-Clonic, Familial |
Nervous System Diseases ; |
0.503 |
0.793 |
Epilepsy, Tonic-Clonic, Symptomatic |
Nervous System Diseases ; |
0.503 |
0.793 |
Atonic Absence Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Fasciculation, Benign |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Hyperkinesia, Generalized |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Multiple Sclerosis, Acute Fulminating |
Nervous System Diseases ; Immune System Diseases ; |
0.503 |
0.793 |
Upper Extremity Paresis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Lower Extremity Paresis |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Convulsive Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures, Focal |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Seizures, Sensory |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Cardiotoxicity |
Pathological Conditions, Signs and Symptoms ; Chemically-Induced Disorders ; Wounds and Injuries ; |
0.503 |
0.793 |
Mammary Neoplasms, Human |
Neoplasms ; Skin and Connective Tissue Diseases ; |
0.503 |
0.793 |
Chromophobe Renal Cell Carcinoma |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Sarcomatoid Renal Cell Carcinoma |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Collecting Duct Carcinoma of the Kidney |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Butyrylcholinesterase deficiency |
Respiratory Tract Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Papillary Renal Cell Carcinoma |
Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; |
0.503 |
0.793 |
Mammary Neoplasms |
Neoplasms ; Skin and Connective Tissue Diseases ; |
0.503 |
0.793 |
Glioblastoma Multiforme |
Neoplasms ; |
0.503 |
0.793 |
Suxamethonium sensitivity |
Respiratory Tract Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Bamforth syndrome |
Musculoskeletal Diseases ; Stomatognathic Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Skin and Connective Tissue Diseases ; Endocrine System Diseases ; |
0.503 |
0.793 |
Acholinesterasemia |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; |
0.503 |
0.793 |
Apnea, Postanesthetic |
Respiratory Tract Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Butyrylcholinesterase Deficiency, Fluoride-Resistant, Japanese Type |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; |
0.503 |
0.793 |
Hypocholinesterasemia, Fluoride-Resistant, Japanese Type |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Nutritional and Metabolic Diseases ; |
0.503 |
0.793 |
Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate |
Musculoskeletal Diseases ; Stomatognathic Diseases ; Congenital, Hereditary, and Neonatal Diseases and Abnormalities ; Skin and Connective Tissue Diseases ; Endocrine System Diseases ; |
0.503 |
0.793 |
Organothiophosphonate Poisoning |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Organothiophosphate Poisoning |
Chemically-Induced Disorders ; |
0.503 |
0.793 |
Nonepileptic Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
BCHE, FLUORIDE 1 PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, FLUORIDE 2 PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, K VARIANT PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, J VARIANT PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, H VARIANT PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE NEWFOUNDLAND PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, SILENT 1 PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE CYNTHIANA PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE JOHANNESBURG PHENOTYPE |
N/A |
0.503 |
0.793 |
APNEA, POSTANESTHETIC, DUE TO BCHE, ATYPICAL-1 |
N/A |
0.503 |
0.793 |
BCHE, DIBUCAINE-RESISTANT I PHENOTYPE |
N/A |
0.503 |
0.793 |
CHE*70G PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*70G PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE ANN ARBOR PHENOTYPE |
N/A |
0.503 |
0.793 |
CHE*FS117 PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*FS117 PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, FLUORIDE-RESISTANT I PHENOTYPE |
N/A |
0.503 |
0.793 |
CHE*243M PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*243M PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, FLUORIDE-RESISTANT II PHENOTYPE |
N/A |
0.503 |
0.793 |
CHE*390V PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*390V PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, QUANTITATIVE K POLYMORPHISM PHENOTYPE |
N/A |
0.503 |
0.793 |
CHE*539T PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*539T PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, QUANTITATIVE J VARIANT PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE, QUANTITATIVE H VARIANT PHENOTYPE |
N/A |
0.503 |
0.793 |
BCHE*FS126 PHENOTYPE |
N/A |
0.503 |
0.793 |
Convulsions |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Absence Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Epileptic Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Myoclonic Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
Generalized Absence Seizures |
Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; |
0.503 |
0.793 |
NO RESULT FOUND |